Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
MannKind Introduces First-and-Only Afrezza® Therapy for Treating Diabetes in Children and Adolescents
MannKind has introduced Afrezza® for the treatment of diabetes in children and adolescents aged six years and older requiring mealtime insulin therapy.
Regeneron Unveils 'First-and-Only' Otarmeni™ (lunsotogene parvec-cwha) for the Treatment of Genetic Hearing Loss
Regeneron Pharmaceuticals has introduced Otarmeni™ (lunsotogene parvec-cwha), the first and only treatment for OTOF-related genetic hearing loss in pediatric and adult patients with severe-to-profound sensorineural hearing loss.
VERTANICAL Introduces Breakthrough VER-01 Therapy for Treating Chronic Low Back Pain
VERTANICAL has introduced VER-01 for the treatment of chronic low back pain, a condition associated with persistent pain and functional impairment.
Wenda Pharma Introduces Breakthrough NHWD-870 Therapy for Treating NUT Carcinoma
Wenda Pharma has introduced NHWD-870 HCl for the treatment of advanced NUT carcinoma, a rare and highly aggressive cancer with limited treatment options and poor survival outcomes.
Merck Introduces Breakthrough Calderasib (MK-1084) Therapy for Treating KRAS G12C-Mutant Non-Small Cell Lung Cancer
Merck has introduced calderasib (MK-1084) for the treatment of newly diagnosed metastatic KRAS G12C-mutant non-small cell lung cancer (NSCLC).
Alkermes Introduces Alixorexton for the Treatment of Narcolepsy Type 1
Alkermes has introduced alixorexton for the treatment of narcolepsy type 1 (NT1), a chronic neurological disorder characterised by excessive daytime sleepiness and disrupted regulation of wakefulness.
Plixorafenib - A Novel Therapy Introduced for the Treatment of High-Grade Glioma
FORE Biotherapeutics has introduced plixorafenib for the treatment of adult patients with BRAF V600E-mutated high-grade glioma (HGG), an aggressive form of brain cancer associated with poor outcomes and limited treatment options.
Sanofi Introduces Breakthrough Venglustat Therapy for Treating Type 3 Gaucher Disease
Sanofi has introduced venglustat for the treatment of neurological manifestations of type 3 Gaucher disease (GD3), a rare inherited lysosomal storage disorder.
Novo Nordisk Introduced First and Only Awiqli® for Type 2 Diabetes
Novo Nordisk has introduced Awiqli® (insulin icodec-abae), the first and only once-weekly basal insulin for adults with type 2 diabetes.
Relay Therapeutics Receives Breakthrough Therapy Designation for Zovegalisib for the Treatment of Advanced Breast Cancer
Relay Therapeutics has introduced zovegalisib for the treatment of patients with PIK3CA-mutant, hormone receptor-positive, HER2-negative advanced breast cancer, a common subtype of breast cancer characterised by mutations that promote tumour growth and progression.
